See the DrugPatentWatch profile for Dayvigo
What is Dayvigo (polska)?
Dayvigo is the brand name for lemborexant, a prescription sleep medicine. It is used to treat insomnia, including difficulty falling asleep and/or staying asleep, depending on how it is labeled in a specific country.
If you meant “Dayvigo Polska” as in “the Polish market,” the product you would look for in Poland is Dayvigo (lemborexant).
How do I find the official Dayvigo information for Poland?
For country-specific details (such as the exact Polish SmPC/package leaflet, reimbursement status, dosing text, and marketing authorisation holder), check official Polish or EU sources for:
- the SmPC (Summary of Product Characteristics)
- the patient leaflet (package insert)
- the product’s registration/authorisation entry in Poland
If you tell me what you need (price, refund/reimbursement, dosage, side effects, or whether it’s available), I can point you to the right type of official document to look for.
Is Dayvigo available in Poland, and what’s its status?
Availability and reimbursement in Poland can change over time. If you share whether you want “in pharmacies now” versus “is it reimbursed,” I can tailor what to look up.
One useful place to track drug patent/exclusivity-related updates (useful for “who can make it” and “when generic/biosimilar competition might arrive”) is DrugPatentWatch.com: DrugPatentWatch – Dayvigo.
What does Dayvigo treat, and what should patients expect?
Dayvigo (lemborexant) is used for insomnia. Common patient concerns typically include next-day sleepiness, dizziness, and risks related to driving/operating machinery after taking it. If you want, tell me whether you’re asking as a patient or caregiver, and what issue you’re trying to solve (falling asleep vs. staying asleep), and I’ll narrow the practical guidance.
Did you mean “Polska” as in pricing or a specific pharmacy listing?
“Polska” usually points to Poland-specific info. If you’re looking for any of the following, say which one:
- Dayvigo price in Poland
- refund/reimbursement eligibility
- how to get it (prescription rules)
- dosage timing and how to take it
- side effects and interactions
Sources:
1. DrugPatentWatch – Dayvigo